Trial Profile
Phase IIa study investigating CX-01 in combination with induction chemotherapy in patients with newly diagnosed primary Acute-myeloid-leukaemia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Jan 2018
Price :
$35
*
At a glance
- Drugs Dociparstat sodium (Primary) ; Antineoplastics
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- Sponsors Cantex Pharmaceuticals
- 05 Jan 2018 New trial record